Although
biosensors based on nanowires-field effect transistor
were proved extraordinarily efficient in fundamental applications,
screening of charges due to the high-ionic strength of most physiological
solutions imposes severe limitations in the design of smart, “real-time”
sensors, as the biosample solution has to be previously desalted.
This work describes the development of a novel nanowire biosensor
that performs extracellular real-time multiplex sensing of small molecular
metabolites, the true indicators of the body’s chemistry machinery,
without any preprocessing of the biosample. Unlike other nanoFET devices
that follow direct binding of analytes to their surfaces, our nanodevice
acts by sensing the oxidation state of redox-reactive chemical species
bound to its surface. The device’s surface array is chemically
modified with a reversible redox molecular system that is sensitive
to H2O2 down to 100 nM, coupled with a suite
of corresponding oxidase enzymes that convert target metabolites to
H2O2, enabling the direct prompt analysis of
complex biosamples. This modality was successfully demonstrated for
the real-time monitoring of cancer cell samples’ metabolic
activity and evaluating chemotherapeutic treatment options for cancer.
This distinctive system displays ultrasensitive, selective, noninvasive,
multiplex, real-time, label-free, and low-cost sensing of small molecular
metabolites in ultrasmall volumes of complex biosamples, in the single-microliter
scale, placing our technology at the forefront of this cutting-edge
field.